Latest Stock Market News

Now just when investors were getting worried about valuations, which are not dirt cheap anymore, and the fall in dividend yield to around 3% at current market prices, the bulls have found another reason to stick to their ground.

"We would like to inform you that the Bank has received an intimation from RBI on July 5, 2023, that it has granted its approval to Tata Asset Management Private Limited (TAMPL) to acquire aggregate holding of up to 7.5% of the paid-up equity capital of the Bank through the schemes of Tata Mutual Fund," DCB Bank said in an exchange filing.

Zee Ent. shares rise 1.97% as Sensex climbs

Updated at : 2023-07-06 11:20:02

Rate this item

(1 Vote)

A total of 278,113 shares changed hands on the counter till 10:15AM (IST)

Rate this item

(1 Vote)

“The key risk in PSU banks remains the squeeze in margins which could start from this quarter as they lose CASA deposits to private sector banks. That is the risk which investors need to be aware of. For HDFC Bank, post-merger, a few quarters are likely to be tough profitability wise.”

The Relative Strength Index of the stock stood at 65.37 on Thursday.

After seeing rampant selling in 2022, shares of most new-age consumer technology companies rebounded sharply in 2023. However, the “Nykaa” brand owner is missing from the list. Shares of Nykaa have given negative returns of more than 7% on a YTD basis and it even touched a 52-week low of Rs 114.25 in April.

Rupee falls 20 paise to 82.45 against US dollar

Updated at : 2023-07-06 11:20:02

Rate this item

(1 Vote)

In the domestic equity market, the 30-share BSE Sensex was trading 23.16 points or 0.04 per cent lower at 65,422.88. The broader NSE Nifty declined 10.25 points or 0.05 per cent to 19,388.25.

​The market structure is going to change across sectors. And I do not think the market is even remotely factoring any of the negatives, which can come from a much different market structure in terms of more players in every segment going forward.

Rate this item

(1 Vote)

Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 43801.84 Crore) operating in Pharmaceuticals sector.

Rate this item

(1 Vote)

The 200-day DMA is used as a key indicator by traders for determining the overall trend in a particular stock.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.